Argus Investors Counsel Inc. cut its holdings in McKesson Co. (NYSE:MCK – Free Report) by 1.1% during the third quarter, Holdings Channel reports. The institutional investor owned 4,570 shares of the company’s stock after selling 53 shares during the period. McKesson makes up about 1.5% of Argus Investors Counsel Inc.’s holdings, making the stock its 20th largest position. Argus Investors Counsel Inc.’s holdings in McKesson were worth $2,260,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors also recently bought and sold shares of MCK. Global Assets Advisory LLC acquired a new stake in McKesson in the first quarter valued at $7,489,000. Gateway Investment Advisers LLC raised its stake in McKesson by 13.9% in the first quarter. Gateway Investment Advisers LLC now owns 4,284 shares of the company’s stock valued at $2,300,000 after buying an additional 523 shares in the last quarter. Riverview Trust Co acquired a new stake in McKesson in the first quarter valued at $49,000. Counterpoint Mutual Funds LLC acquired a new stake in shares of McKesson during the first quarter worth about $394,000. Finally, Kingswood Wealth Advisors LLC increased its position in shares of McKesson by 7.7% during the first quarter. Kingswood Wealth Advisors LLC now owns 1,531 shares of the company’s stock worth $822,000 after purchasing an additional 110 shares in the last quarter. 85.07% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
A number of analysts have recently commented on MCK shares. JPMorgan Chase & Co. lifted their target price on McKesson from $656.00 to $661.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 21st. Citigroup cut their target price on McKesson from $670.00 to $630.00 and set a “buy” rating on the stock in a research report on Tuesday, September 10th. Argus lifted their target price on McKesson from $570.00 to $670.00 and gave the stock a “buy” rating in a research report on Monday, June 24th. Wells Fargo & Company cut their target price on McKesson from $576.00 to $535.00 and set an “equal weight” rating on the stock in a research report on Friday, September 13th. Finally, Evercore ISI cut their target price on McKesson from $660.00 to $630.00 and set an “outperform” rating on the stock in a research report on Thursday, August 8th. Five research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $610.86.
Insider Activity
In other news, CEO Brian S. Tyler sold 3,753 shares of the firm’s stock in a transaction dated Monday, August 5th. The stock was sold at an average price of $626.03, for a total transaction of $2,349,490.59. Following the completion of the sale, the chief executive officer now directly owns 82,339 shares in the company, valued at $51,546,684.17. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 0.11% of the company’s stock.
McKesson Trading Down 0.4 %
NYSE:MCK traded down $1.99 during mid-day trading on Tuesday, hitting $506.33. The company had a trading volume of 134,025 shares, compared to its average volume of 804,445. The business has a fifty day simple moving average of $520.24 and a 200-day simple moving average of $551.96. The firm has a market capitalization of $65.79 billion, a price-to-earnings ratio of 22.71, a PEG ratio of 1.17 and a beta of 0.44. McKesson Co. has a 1 year low of $431.35 and a 1 year high of $637.51.
McKesson (NYSE:MCK – Get Free Report) last announced its earnings results on Wednesday, August 7th. The company reported $7.88 earnings per share for the quarter, beating the consensus estimate of $7.21 by $0.67. The company had revenue of $79.28 billion during the quarter, compared to the consensus estimate of $82.53 billion. McKesson had a negative return on equity of 242.57% and a net margin of 0.94%. The company’s revenue was up 6.4% on a year-over-year basis. During the same period last year, the firm earned $7.27 earnings per share. As a group, research analysts anticipate that McKesson Co. will post 32.07 earnings per share for the current year.
McKesson Increases Dividend
The firm also recently announced a quarterly dividend, which was paid on Tuesday, October 1st. Stockholders of record on Monday, September 2nd were paid a dividend of $0.71 per share. The ex-dividend date of this dividend was Friday, August 30th. This is an increase from McKesson’s previous quarterly dividend of $0.62. This represents a $2.84 annualized dividend and a dividend yield of 0.56%. McKesson’s dividend payout ratio (DPR) is currently 12.69%.
McKesson Company Profile
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.
See Also
- Five stocks we like better than McKesson
- Where Do I Find 52-Week Highs and Lows?
- How Verizon Could Offer Stress-Free Double-Digit Returns in 2025
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Can Roche Challenge Lilly and Novo in the Weight Loss Market?
- How to Read Stock Charts for Beginners
- Roblox Stock: Key Metrics Surge, Is This the Perfect Entry?
Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Co. (NYSE:MCK – Free Report).
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.